POST Online Media Lite Edition



 

Researchers develop synthetic T cells

Staff Writer |
UCLA researchers have developed synthetic T lymphocytes, or T cells, that are near-perfect facsimiles of human T cells.

Article continues below




The ability to create the artificial cells could be a key step toward more effective drugs to treat cancer and autoimmune diseases and could lead to a better understanding of human immune cells' behavior.

Such cells also could eventually be used to boost the immune system of people with cancer or immune deficiencies.

The research team comprised scientists from the UCLA School of Dentistry, the UCLA Samueli School of Engineering and the department of chemistry and biochemistry in the UCLA College, and was led by Dr. Alireza Moshaverinia, an assistant professor of prosthodontics at the dental school. The findings are published in the journal Advanced Materials.

"The complex structure of T cells and their multifunctional nature have made it difficult for scientists to replicate them in the lab," Moshaverinia said. "With this breakthrough, we can use synthetic T cells to engineer more efficient drug carriers and understand the behavior of immune cells."

Natural T cells are difficult to use in research because they're very delicate, and because after they're extracted from humans and other animals, they tend to survive for only a few days.

"We were able to create a novel class of artificial T cells that are capable of boosting a host's immune system by actively interacting with immune cells through direct contact, activation or releasing inflammatory or regulatory signals," said Mohammad Mahdi Hasani-Sadrabadi, an assistant project scientist at UCLA Samueli.

"We see this study's findings as another tool to attack cancer cells and other carcinogens."

T cells play a key role in the immune system. They are activated when infection enters the body and they flow through the bloodstream to reach the infected areas.

Because they must squeeze between small gaps and pores, T cells have the ability to deform to as small as one-quarter of their normal size.

They also can grow to almost three times their original size, which helps them fight off or overcome the antigens that attack the immune system.

Until recently, bioengineers hadn't been able to mimic the complex nature of human T cells. But the UCLA researchers were able to replicate their shape, size and flexibility, which enable it to perform its basic functions of targeting and homing in on infections.

The team fabricated T cells using a microfluidic system. (Microfluidics focuses on the behavior, control and manipulation of fluids, typically on a submillimeter scale.) They combined two different solutions -- mineral oil and an alginate biopolymer, a gum-like substance made from polysaccharides and water.

When the two fluids combine, they create microparticles of alginate, which replicate the form and structure of natural T cells. The scientists then collected the microparticles from a calcium ion bath, and adjusted their elasticity by changing the concentration of calcium ions in the bath.

Once they had created T cells with the proper physical properties, the researchers needed to adjust the cells' biological attributes -- to give them the same traits that enable natural T cells to be activated to fight infection, penetrate human tissue and release cellular messengers to regulate inflammation.

To do that, they coated the T cells with phospholipids, so that their exterior would closely mimic human cellular membranes. Then, using a chemical process called bioconjugation, the scientists linked the T cells with CD4 signalers, the particles that activate natural T cells to attack infection or cancer cells.

Moshaverinia said other scientists could use the same process to create various types of artificial cells, such as natural killer cells or microphages, for research on specific diseases or to help develop treatments; in the future, the approach could help scientists develop a database of a wide range of synthetic cells that mimic human cells.

The study's other authors, all of UCLA, are graduate student Fatemah Majedi; Steven Bensinger, a professor of microbiology, immunology and molecular genetics; Dr. Ben Wu, a professor of dentistry and bioengineering; Louis Bouchard, an associate professor of chemistry and biochemistry; and Paul Weiss, a distinguished professor of chemistry and biochemistry.

Bensinger, Bouchard and Weiss are also members of the UCLA Jonsson Comprehensive Cancer Center.


What to read next

Cancer cells play hide-and-seek with immune system
Researchers find how cancer cells may become resistant to drugs
Miniature human hearts created from rat hearts

Lomar Shipping announces acquisition of Carl Büttner Holding

 
Lomar Shipping, a maritime subsidiary of Libra Group, has acquired the Bremen, Germany-based Carl Büttner Holding.
 
 

Latest

Pfizer completes $11.6bn acquisition of Biohaven Pharmaceuticals
United Airlines suspends service to New York JFK
Companies increasingly pessimistic about Swiss economy
EU antitrust watchdog in talks with Germany over 200 bln euro support plan

NEWS

Explosion in chemical factory in Uzbekistan

Indiana AG: Make sure your social media accounts are safe after you die
U.S.: Variety of weather hazards to start off the week
Hurricane Orlene expected to hit Mexico
Russian nuclear submarine disappeared from NATO radars
Swedish Coast Guard issues update on gas leaks in Baltics
 

BUSINESS

Plan for big boost in GP training numbers in New Zealand

World’s tallest timber apartment tower to be built in Zanzibar
950,000 Singaporean households to get rebate for up to 10 months of bills
Seven vessels with foodstuffs leave Ukrainian ports
Site of UK’s first fusion energy plant selected
AG Ferguson: Half-billion dollars to fight opioid epidemic will start flowing December 1
 

Trending Now

Rockwell Automation to buy CUBIC

Alfa Laval signs global partnership agreement with Spirax Sarco

Alexion, AstraZeneca Rare Disease to acquire LogicBio Therapeutics

World’s tallest timber apartment tower to be built in Zanzibar


POLITICS

There must be no return to austerity, says Murphy

U.S. Treasury takes additional sanctions actions across Bosnia and Herzegovina
Libya, Türkiye sign MoU for oil, gas cooperation
Commission approves €800 million Greek scheme to support non-household electricity consumers
Commission approves €134 million German measure to support BASF in production of renewable hydrogen
North Dakota Governor leads trade and investment mission to Japan
 

Today We Recommend

950,000 Singaporean households to get rebate for up to 10 months of bills


Highlights 

ABB wins $170 million in orders from Stadler Valencia to enhance Europe’s railway network

PwC expects remainder of 2022 and 2023 to be challenging

PwC announces record global revenues of $50 billion


COMPANIES

ORLEN Group launching new petrochemical product

Cambrex announces stability storage expansions in Ireland and Belgium
Excelerate Energy finalizes agreement with Hyundai Heavy Industries for for floating regasification and storage unit
LyondellBasell starts production at its Frankfurt site
Alfa Laval signs global partnership agreement with Spirax Sarco
Duke Energy commits $250,000 to support Hurricane Ian relief efforts
 

CAREERS

Ara Partners hires Teresa O'Flynn as partner and co-lead of infrastructure strategy

Kimberly Nelson named president of Kemin Nutrisurance
Discovery Life Sciences appoints Suso J. Platero as chief scientific officer
Sandeep Johri joins LambdaTest board
Skyresponse appoints Mats Berthem as new CEO
Phathom Pharmaceuticals appoints James Toppe to board
 

ECONOMY

U.S. construction spending decreases more than expected in August

Manufacturing PMI at 50.9% September
PwC expects remainder of 2022 and 2023 to be challenging
Turkish inflation rate hits 24-year high of 83%
Japan consumer confidence deteriorates but remains in positive territory in September
Poland inflation comes in at highest level since February 1997 in September
 

EARNINGS

PwC announces record global revenues of $50 billion

AllianceBernstein's fund net assets 377,335,035
CarMax Q2 revenues $8.1 billion
Rite Aid Q2 net loss $331.3 million
NIKE Q1 2023 revenues $12.7 billion
Morrisons Q3 revenue up 4.5%
 

OP-ED

Micromanaging is the worst enemy of efficiency and teamwork

Niger set to monetize massive gas reserves through Saharan natural gas pipeline
Putting the brakes on EV folly that choked the market
Oil discovery in Kavango Basin may mean huge benefits for Namibians
Cape Town and Dubai battle over Africa's energy future
Is America going to lose its superpower status?
 

AGRIFISH

Utah confirms additional 3 cases of HPAI on turkey farms in Sanpete County

Oregon: HPAI confirmed in Douglas County backyard flock
Russia: Over 23 thousand tons of grain, processing products sent for export from Primorye
Netherlands to cull around 102,000 chickens to contain bird flu
Rosselkhoznadzor found about 73 tons of infected vegetables and fruits in Dagestan
Farmers in Guyana to training to improve and sustain their incomes
 

LEADERSHIP

Forget everything you know about hiring people

Cybervetting can have pronounced impact on workforce by broadening discrimination
Female managers pay fairer
Pitch quality of CEO voices rests entirely on gender
Employee turnover costs more than you think
51% of supply chain leaders increased number of network locations
 

CRIME

Kim Kardashian to pay $1.26 million for unlawfully touting crypto security after SEC charges

SEC charges two Canadian programmers for GlobeNewswire with insider trading
Barclays agrees to $361 million settlement to resolve SEC charges relating to over-issuances of securities
Justice department announces total distribution of over $4 billion to victims of Madoff Ponzi Scheme
Bank of Ireland fined EUR100.5 million over tracker mortgage dispute
11 financial institutions to pay over $710m for recordkeeping and supervision failures, unapproved communication
 

Magazine

TRAVEL

Come to the astronomy capital of the world and meet the stars

All New Zealand fans of all things home and garden are welcome to Hamilton
Sanctuary Cap Cana opens in Dominican Republic
Skate with Olympic star Patrick Chan at Vancouver rinks
Annual Peanut Festival in Aubrey, Tx. is celebration of past and joy of present
Anantara Grand Hotel Krasnapolsky Amsterdam opens
 

SEA, LAND, AIR

2023 Ford F-Series Super Duty, built like never before

Caterham Super Sevens, true joy of ride
New Ford Mustang brings digital cockpit, new engines and style
Ram 1500 Limited Elite Edition joins lineup for 2023
2023 GMC Canyon AT4X, new midsize truck
Shelby Code Red, $210,000+ to upgrade your Ford Mustang
 

DESIGN

Noritake tableware, to pass down to the new generation as an heirloom

Tecnografica wallcoverings from the land of ceramic
Poliform, kitchens for extraordinary homes
Luxury vinyl tiles, ideal combination of everything
LED lamps, long-lasting light for every space in your home
Clean and luxurious men's watches
 

GADGETS

Technics SL-1200, the legend keeps spinning

Leica S3, made in Germany for great pictures
Sennheiser HD 300 PROtect, pro headphones that protect your ears
HP Dragonfly Folio G3, very very good laptop for business users
Nokia PureBook Fold and PureBook Lite, flexibility and stylish design
Tascam 202MKVII, professional dual cassette deck
 

HEALTH

Roche launches its next-generation SARS-CoV-2 Rapid Antibody Test

FDA approves Taiho's LYTGOBI (futibatinib) tablets
New recommendations for terlipressin-containing medicines in treatment of hepatorenal syndrome
Singapore authorises Pfizer COVID-19 vaccine for children aged 6 months through 4 years
Russia’s Vector Center developing mRNA coronavirus vaccine
Shionogi says COVID pill resolves Omicron symptoms faster
 

MEANTIME

Three scientists share Nobel Prize in Physics for work in quantum mechanics

Swedish scientist Svante Pääbo wins Nobel Prize in medicine for discoveries on human evolution
First probable impact crater discovered in Spain
New evidence for liquid water beneath south polar ice cap of Mars
Potential first traces of the universe's earliest stars
New archaeology dives into mysterious demise of Neanderthals